TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Global Cord Blood ( (CORBF) ) is now available.
On September 1, 2025, the joint provisional liquidators (JPLs) of Global Cord Blood Corporation submitted their thirteenth report to the Grand Court of the Cayman Islands. This report marks a continuation of the company’s ongoing provisional liquidation process, which began on September 22, 2022. The release of this report may have implications for stakeholders, as it provides insights into the company’s current financial status and the progress of its restructuring efforts.
More about Global Cord Blood
Global Cord Blood Corporation is a company operating in the healthcare industry, primarily focused on the collection, storage, and research of umbilical cord blood stem cells. The company serves a significant role in the medical and biotechnology fields, providing services that are crucial for regenerative medicine and various therapeutic applications.
Average Trading Volume: 12,113
Technical Sentiment Signal: Sell
Current Market Cap: $140.6M
For detailed information about CORBF stock, go to TipRanks’ Stock Analysis page.